Publications:108
Marcio Diniz, PhD
About Me
Marcio Diniz, PhD, is Associate Professor of Population Health Science and Policy at the Icahn School of Medicine at Mount Sinai and Director of the Biostatistics and Clinical Informatics Shared Resource at the Mount Sinai Tisch Cancer Center. His research is focused on design of adaptive clinical trials. He has developed statistical tools to design more efficient trials, reducing the number of patients in phase I trials and false positive results in phase II trials. Dr. Diniz has extensive experience providing statistical support to clinical investigators using conventional statistical and novel methods, with strict attention to good practices to ensure statistical rigor and reproducible research.
Language
English
Position
ASSOCIATE PROFESSOR | Population Health Science and Policy
Education
Statistics, University of São Paulo
Publications
Selected Publications
- Protocol for a cluster randomized trial to evaluate a faith-based breast cancer screening navigation model. Gillian Gresham, Dong Hee Kim, Min Jung Sung, Marcio A. Diniz, Laurel Finster, Michael Fine, Christie Jeon, Alison K. Herrmann, Jeong Yup Lee, Zulfikarali Surani, Robert W. Haile. Trials
- Evaluating tocilizumab in ischemic stroke: Findings from the SPAN multicenter trial. Anjali Chauhan, Eunyoung Angela Lee, Rakesh B. Patel, Mariia Kumskova, Enrique C. Leira, Anil K. Chauhan, Yanrong Shi, Suyi Cao, Raymond C. Koehler, Krishnan M. Dhandapani, Mohammad Badruzzaman Khan, Pradip K. Kamat, Ali Arbab, David C. Hess, Alison L. Herman, Ligia Boisserand, Lauren H. Sansing, Andreia Morais, Xuyan Jin, Sanem Aykan, Takahiko Imai, Cenk Ayata, Karisma A. Nagarkatti, Jessica Lamb, Márcio A. Diniz, Patrick D. Lyden, Louise D. McCullough, Jaroslaw Aronowski. Neuropharmacology
- Methods for randomized, blinded, controlled evaluation of putative disease interventions in multilaboratory, preclinical assessment networks. Jessica Lamb, Karisma Nagarkatti, Marcio A. Diniz, Ryan Cabeen, Monica Estrada, Karen L. Crawford, Andre Rogatko, Sungjin Kim, Cenk Ayata, David C. Hess, Mohammad Badruzzaman Khan, Rakesh B. Patel, Mariia Kumskova, Enrique C. Leira, Anil K. Chauhan, Steve Zeiler, Lili Yu, Jiadi Xu, Kristofer Wood, Nicholas Wilder, Jun Wang, Sofia Velazquez, Peter Van Zijl, Klaus van Leyen, Shun Mug Ting, Thedens Dan Thedens, W. Taylor Kimberly, Brijesh Sutariya, Guanghua Sun, Cameron Smith, Shahneela Siddiqui, Yanrong Shi, Lauren Sansing, Basavaraju Sanganahilli Ganganna, Tao Qin, Lidiya Obertas, Mohammad Nisar, Steward Niefert, Diego Motales-Scheihing, Andreia Morais, Louise McCullough, Michael Maniskas, Joe Mandeville, Eng Lo, Siyue Li, Steven Lannon, Javier Labastida, Ewa Kulikowicz, Raymond Koehler, Senthilkumar Karuppagounder. Lab Animal
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Diniz during 2025 and/or 2026. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
- Bloomer Health Tech Inc
- Comanche Biopharma
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.